Findings from a recent phase 3 trial show promising results for the approval of ziresovir in the treatment of respiratory syncytial virus in infants.
Erin Torrance, PharmD candidate
Advertisement
Torrance is a class of 2025 PharmD candidate at Temple University
School of Pharmacy in Philadelphia, Pennsylvania.
Articles by Erin Torrance, PharmD candidate
Advertisement
Latest Updated Articles
Respiratory Syncytial Viral Infection: Treatment With Ziresovir in InfantsPublished: January 12th 2025 | Updated:
Advertisement
Advertisement
